Back to Top Skip to main content

HPV vaccine age limit raised by FDA to age 45

https://www.nfid.org/infectious-diseases/hpv/ Recent CDC and FDA guidance recommends that men and women up to 45 years of age get vaccinated to protect against the Human papillomavirus (HPV). HPV is the most common sexually transmitted infection and can cause certain cancers and genital warts. More than 14 million new HPV infections occur in the U.S. each year, and about 80 percent of sexually active men and women are infected with HPV at some point in their lives. (National Foundation for Infectious Diseases image) Recent CDC and FDA guidance recommends that men and women up to 45 years of age get vaccinated to protect against the Human papillomavirus (HPV). HPV is the most common sexually transmitted infection and can cause certain cancers and genital warts. More than 14 million new HPV infections occur in the U.S. each year, and about 80 percent of sexually active men and women are infected with HPV at some point in their lives. (National Foundation for Infectious Diseases image)

Recommended Content:

Conditions and Treatments | Health Readiness | Preventive Health | Men's Health | Women's Health | Immunization Healthcare | Vaccine-Preventable Diseases | Vaccine Recommendations

The Food and Drug Administration has raised the recommended age to receive the vaccine for human papillomavirus, or HPV to 45. Health care experts say that's good news for women and men who did not receive the anti-cancer vaccine in childhood.

"There are hundreds of different strains of HPV," said Navy Cmdr. Shannon Lamb, a urogynecologist and the U.S. Navy Bureau of Medicine and Surgery's Women's Health Branch chief. "The vaccine doesn't protect from all of them, but it does protect from the most common ones that cause different types of cancers as well as genital warts."

HPV spreads through intimate skin-on-skin contact. Typically, the vaccine is recommended for girls and boys as young as age 9, and women and men up to age 26.

“It's recommended for young people so they're protected before they're ever exposed to the virus," Lamb said. "HPV is a very common infection. Over 80 percent of people will be infected in their lifetime."

In 2018, the FDA approved the vaccine for women and men up to age 45. While many adults have been exposed to some strains of HPV, most have not been exposed to all nine types covered by the vaccine.

"Therefore, expanding the age range for vaccination can help prevent HPV-related diseases in more individuals," she said.

Usually, people don't exhibit any signs or symptoms of an HPV infection, and most won't develop health problems related to HPV. The virus typically goes away on its own after a couple of years. But there's no way to predict who will clear the virus and who won't. And for those who don't, the consequences can be deadly.

According to the Centers for Disease Control and Prevention, HPV is responsible for more than 90 percent of all cervical and anal cancers, 70 percent of vaginal and vulvar cancers, and more than 60 percent of penile cancers. Every year, approximately 25,000 women and 19,000 men are affected by cancers caused by HPV.

For HPV vaccination of service members, the Department of Defense follows guidelines published by the Advisory Committee on Immunization Practices. ACIP recommends shared clinical decision-making regarding HPV vaccination for some adults ages 27-45 who aren't adequately vaccinated. Lamb notes the vaccine isn't mandatory, but it's strongly recommended for eligible service members.

"The vaccine creates a lot of benefit for men and women," Lamb said, "and we know it works." The number of cases of genital warts in the United States has dramatically declined in the military as well as civilian populations since the vaccine was introduced, she said.

"The HPV vaccine is definitely making an impact," Lamb said. "But we're still missing a good chunk of the population that could benefit."

The vaccine is administered as a two-dose series for those under age 15, and a three-dose series for older people. According to data from the Armed Forces Health Surveillance Branch's Medical Surveillance Monthly Report, only 26.6 percent of eligible servicewomen ages 17-26 initiated the vaccine during 2007-2017. During the same time period, only 5.8 percent of eligible servicemen in the same age group did so.

Further, for those who did initiate the vaccine and then remained in service for at least six months, only 46.6 percent of servicewomen and 35.1 percent of servicemen completed the recommended three doses.

"I think there's a lot of misinformation about the HPV vaccine," Lamb said. "Parents may think their kids don’t need it because they're not yet sexually active, for example, and older people may not understand they may be at risk."

Lamb is hopeful that with awareness people will make it a priority to talk to their health care providers about their risk for new HPV infections and the possible benefits of vaccination.

She notes that cancers caused by HPV may take years to develop after a person contracts the virus. Further, while there are cervical HPV screening tests available for women for high risk strains, there are no routine screening tests for men or tests that include all strains of HPV. Over 12,000 women living in the United States will be diagnosed with cervical cancer, and over 4,000 women die from cervical cancer annually. Women at highest risk are those who don’t undergo recommended screening and are not vaccinated, as well as women who smoke or have lowered immune systems.

TRICARE covers the HPV vaccine as recommended by the CDC. More information about the HPV vaccine can be found on the TRICARE website.

You also may be interested in...

Immunization Tool Kit 9th Edition

Publication
9/25/2020

A practical reference that facilitates and enhances the global delivery of quality immunization healthcare to Department of Defense (DoD) beneficiaries and employees. The Defense Health Agency Immunization Healthcare Division (DHA-IHD) publishes the Immunization Tool Kit based on national recommendations, evidenced-based, peer-reviewed published medical literature, and clinical practice guidelines.

Recommended Content:

Immunization Healthcare

3D Mammography Toolkit

Publication
12/19/2019

Recommended Content:

MHS Toolkits | TRICARE Health Program | Women's Health

3D Mammography Infographic 1

Publication
12/16/2019

Share this infographic to spread the word about 3-D Mammography coverage

Recommended Content:

TRICARE Health Program | Women's Health | MHS Toolkits

3D Mammography Infographic 2

Publication
12/16/2019

Share this infographic to spread the word about 3-D Mammography coverage

Recommended Content:

TRICARE Health Program | Women's Health | MHS Toolkits

Talking_Points_3D_Mammography

Publication
12/16/2019

These talking points share information about 3-D mammography

Recommended Content:

TRICARE Health Program | Women's Health | MHS Toolkits

McCaffery AMSUS Remarks 2019

Publication
12/5/2019

McCaffery statements made during the 2019 annual meeting of AMSUS

Recommended Content:

Health Readiness

2019 Men's Health Case Studies

Publication
6/27/2019

This chart summarizes case studies of adult male patients in different life stages

Recommended Content:

Men's Health

Checklist: Best Practices for Vaccination Clinics Held at Satellite, Temporary, or Off-Site Locations

Publication
6/21/2019

A step-by-step guide to help clinic supervisors follow Centers for Disease Control and Prevention (CDC) and Department of Defense (DoD) guidelines while overseeing any nontraditional vaccination clinic setting.

Recommended Content:

Immunization Healthcare | Vaccine-Preventable Diseases | Vaccine Storage and Handling

Administering Vaccines to Adults: Dose, Route, Site, and Needle Size

Publication
6/1/2019

An illustrated reference guide showing how to administer vaccines to adults.

Recommended Content:

Vaccine-Preventable Diseases

Immunization University Certificate Retrieval Instructions

Publication
2/14/2018

This document provides instructions for students to retrieve their certificates for Immunization University courses

Recommended Content:

Immunization Healthcare

DoDEA Immunization Requirements School Year 2017-18

Publication
5/26/2017

Students who enroll in Department of Defense Education Activity (DoDEA) schools are required to meet specific immunization requirements.

Recommended Content:

Immunization Healthcare | Vaccine Schedules

Smallpox Vaccine in Pregnancy

Publication
2/26/2016

The National Smallpox Vaccine in Pregnancy Registry was created to follow the pregnancy outcomes of women who were exposed to the smallpox vaccine during pregnancy.

Recommended Content:

Smallpox (ACAM2000) | Women's Health
Showing results 1 - 12 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.